EGFR Amplification and Sensitizing Mutations Correlate with Survival in Lung Adenocarcinoma Patients Treated with Erlotinib (MutP-CLICaP) (English)
- New search for: Ruiz-Patiño, A.
- New search for: Castro, C. D.
- New search for: Ricaurte, L. M.
- New search for: Cardona, A. s.
- New search for: Rojas, L.
- New search for: Zatarain-Barrón, Z. L.
- New search for: Wills, B.
- New search for: Reguart, N.
- New search for: Carranza, H. n.
- New search for: Vargas, C.
- New search for: Ruiz-Patiño, A.
- New search for: Castro, C. D.
- New search for: Ricaurte, L. M.
- New search for: Cardona, A. s.
- New search for: Rojas, L.
- New search for: Zatarain-Barrón, Z. L.
- New search for: Wills, B.
- New search for: Reguart, N.
- New search for: Carranza, H. n.
- New search for: Vargas, C.
In:
TARGETED ONCOLOGY
;
13
, 5
;
621-629
;
2018
-
ISSN:
- Article (Journal) / Print
-
Title:EGFR Amplification and Sensitizing Mutations Correlate with Survival in Lung Adenocarcinoma Patients Treated with Erlotinib (MutP-CLICaP)
-
Contributors:Ruiz-Patiño, A. ( author ) / Castro, C. D. ( author ) / Ricaurte, L. M. ( author ) / Cardona, A. s. ( author ) / Rojas, L. ( author ) / Zatarain-Barrón, Z. L. ( author ) / Wills, B. ( author ) / Reguart, N. ( author ) / Carranza, H. n. ( author ) / Vargas, C. ( author )
-
Published in:TARGETED ONCOLOGY ; 13, 5 ; 621-629
-
Publisher:
- New search for: Springer Nature
-
Publication date:2018-01-01
-
Size:9 pages
-
ISSN:
-
Type of media:Article (Journal)
-
Type of material:Print
-
Language:English
- New search for: 616.994
- Further information on Dewey Decimal Classification
-
Classification:
DDC: 616.994 -
Source:
© Metadata Copyright the British Library Board and other contributors. All rights reserved.
Table of contents – Volume 13, Issue 5
The tables of contents are generated automatically and are based on the data records of the individual contributions available in the index of the TIB portal. The display of the Tables of Contents may therefore be incomplete.
- 541
-
Tumor Type-Agnostic Treatment and the Future of Cancer TherapyRaez, L. E. / Santos, E. S. et al. | 2018
- 545
-
TRK Inhibition: A New Tumor-Agnostic Treatment StrategyKummar, S. / Lassen, U. N. et al. | 2018
- 557
-
Targeted Therapies in the Treatment of SarcomasHoffner, B. / Elias, A. D. / Villalobos, V. M. et al. | 2018
- 567
-
Treatment of Advanced Merkel Cell Carcinoma: Current Therapeutic Options and Novel Immunotherapy ApproachesFemia, D. / Prinzi, N. / Anichini, A. / Mortarini, R. / Nichetti, F. / Corti, F. / Torchio, M. / Peverelli, G. / Pagani, F. / Maurichi, A. et al. | 2018
- 583
-
Targeting Toll-Like Receptors for Cancer TherapyBraunstein, M. J. / Kucharczyk, J. / Adams, S. et al. | 2018
- 599
-
Immunological Correlates of Response to Immune Checkpoint Inhibitors in Metastatic Urothelial CarcinomaTzeng, A. / Diaz-Montero, C. M. / Rayman, P. A. / Kim, J. S. / Pavicic, P. G. / Finke, J. H. / Barata, P. C. / Lamenza, M. / Devonshire, S. / Schach, K. et al. | 2018
- 611
-
Immediate Progressive Disease in Patients with Metastatic Renal Cell Carcinoma Treated with Nivolumab: a Multi-Institution Retrospective StudyIshihara, H. / Kondo, T. / Takagi, T. / Tachibana, H. / Fukuda, H. / Yoshida, K. / Iizuka, J. / Kobayashi, H. / Tanabe, K. et al. | 2018
- 621
-
EGFR Amplification and Sensitizing Mutations Correlate with Survival in Lung Adenocarcinoma Patients Treated with Erlotinib (MutP-CLICaP)Ruiz-Patiño, A. / Castro, C. D. / Ricaurte, L. M. / Cardona, A. s. / Rojas, L. / Zatarain-Barrón, Z. L. / Wills, B. / Reguart, N. / Carranza, H. n. / Vargas, C. et al. | 2018
- 631
-
Characteristics and Response to Crizotinib in ALK-Rearranged, Advanced Non-Adenocarcinoma, Non-Small Cell Lung Cancer (NA-NSCLC) Patients: a Retrospective Study and Literature ReviewZhang, B. / Zhang, Y. / Xu, J. / Zhang, X. / Chu, T. / Wang, S. / Qian, J. / Qiao, R. / Lu, J. / Zhang, L. et al. | 2018
- 641
-
Everolimus Exposure and Early Metabolic Response as Predictors of Treatment Outcomes in Breast Cancer Patients Treated with Everolimus and ExemestaneWillemsen, A. E. / Geus-Oei, L. F. / Boer, M. / Tol, J. / Kamm, Y. / Jong, P. C. / Jonker, M. A. / Vos, A. H. / Grootjans, W. / Groot, J. W. et al. | 2018
- 649
-
Comparison Between Prognostic Classifications in De Novo Metastatic Hormone Sensitive Prostate CancerIacovelli, R. / Ciccarese, C. / Mosillo, C. / Bimbatti, D. / Fantinel, E. / Stefani, L. / Simbolo, M. / Romano, M. / Mazzarotto, R. / Brunelli, M. et al. | 2018
- 657
-
Vitamin D Deficiency has a Negative Impact on Cetuximab-Mediated Cellular Cytotoxicity against Human Colon Carcinoma CellsMortara, L. / Gariboldi, M. B. / Bosi, A. / Bregni, M. / Pinotti, G. / Guasti, L. / Squizzato, A. / Noonan, D. M. / Monti, E. / Campiotti, L. et al. | 2018
- 667
-
Correction to: Medical Treatment Options for Patients with Epidermal Growth Factor Receptor Mutation-Positive Non-Small Cell Lung Cancer Suffering from Brain Metastases and/or Leptomeningeal DiseaseHochmair, M. et al. | 2018